These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 24122992)

  • 21. Inhibitor of differentiation 4 (ID4): From development to cancer.
    Patel D; Morton DJ; Carey J; Havrda MC; Chaudhary J
    Biochim Biophys Acta; 2015 Jan; 1855(1):92-103. PubMed ID: 25512197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intra-tumoral delivery of functional ID4 protein via PCL/maltodextrin nano-particle inhibits prostate cancer growth.
    Korang-Yeboah M; Patel D; Morton D; Sharma P; Gorantla Y; Joshi J; Nagappan P; Pallaniappan R; Chaudhary J
    Oncotarget; 2016 Oct; 7(42):68072-68085. PubMed ID: 27487149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Knockdown of AGR2 induces cellular senescence in prostate cancer cells.
    Hu Z; Gu Y; Han B; Zhang J; Li Z; Tian K; Young CY; Yuan H
    Carcinogenesis; 2012 Jun; 33(6):1178-86. PubMed ID: 22467239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ID4: a new player in the cancer arena.
    Dell'Orso S; Ganci F; Strano S; Blandino G; Fontemaggi G
    Oncotarget; 2010 May; 1(1):48-58. PubMed ID: 21293053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p16( INK4a) positively regulates cyclin D1 and E2F1 through negative control of AUF1.
    Al-Khalaf HH; Colak D; Al-Saif M; Al-Bakheet A; Hendrayani SF; Al-Yousef N; Kaya N; Khabar KS; Aboussekhra A
    PLoS One; 2011; 6(7):e21111. PubMed ID: 21799732
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The expression pattern of Id4, a novel dominant negative helix-loop-helix protein, is distinct from Id1, Id2 and Id3.
    Riechmann V; van Crüchten I; Sablitzky F
    Nucleic Acids Res; 1994 Mar; 22(5):749-55. PubMed ID: 8139914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Erythropoietin inhibits chemotherapy-induced cell death and promotes a senescence-like state in leukemia cells.
    Pham TD; Ma W; Miller D; Kazakova L; Benchimol S
    Cell Death Dis; 2019 Jan; 10(1):22. PubMed ID: 30622244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A previously identified apoptosis inhibitor iASPP confers resistance to chemotherapeutic drugs by suppressing senescence in cancer cells.
    Li H; Zhang W; Zhao K; Zhao D; Zheng S; Hu Y
    J Biol Chem; 2020 Mar; 295(12):4049-4063. PubMed ID: 32005663
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p16/MTS1/INK4A suppresses prostate cancer by both pRb dependent and independent pathways.
    Steiner MS; Wang Y; Zhang Y; Zhang X; Lu Y
    Oncogene; 2000 Mar; 19(10):1297-306. PubMed ID: 10713671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TFDP3 was expressed in coordination with E2F1 to inhibit E2F1-mediated apoptosis in prostate cancer.
    Ma Y; Xin Y; Li R; Wang Z; Yue Q; Xiao F; Hao X
    Gene; 2014 Mar; 537(2):253-9. PubMed ID: 24406621
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epithelial cell-derived periostin functions as a tumor suppressor in gastric cancer through stabilizing p53 and E-cadherin proteins via the Rb/E2F1/p14ARF/Mdm2 signaling pathway.
    Lv H; Liu R; Fu J; Yang Q; Shi J; Chen P; Ji M; Shi B; Hou P
    Cell Cycle; 2014; 13(18):2962-74. PubMed ID: 25486483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PC3, but not DU145, human prostate cancer cells retain the coregulators required for tumor suppressor ability of androgen receptor.
    Litvinov IV; Antony L; Dalrymple SL; Becker R; Cheng L; Isaacs JT
    Prostate; 2006 Sep; 66(12):1329-38. PubMed ID: 16835890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evasion of a single-step, chemotherapy-induced senescence in breast cancer cells: implications for treatment response.
    Elmore LW; Di X; Dumur C; Holt SE; Gewirtz DA
    Clin Cancer Res; 2005 Apr; 11(7):2637-43. PubMed ID: 15814644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression and regulation of inhibitor of DNA binding proteins ID1, ID2, ID3, and ID4 at the maternal-conceptus interface in pigs.
    Han J; Seo H; Choi Y; Lee C; Kim MI; Jeon Y; Lee J; Hong M; Hyun SH; Lee E; Ka H
    Theriogenology; 2018 Mar; 108():46-55. PubMed ID: 29197292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The MDM2 antagonist nutlin-3 sensitizes p53-null neuroblastoma cells to doxorubicin via E2F1 and TAp73.
    Peirce SK; Findley HW
    Int J Oncol; 2009 May; 34(5):1395-402. PubMed ID: 19360352
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Doxorubicin anti-tumor mechanisms include Hsp60 post-translational modifications leading to the Hsp60/p53 complex dissociation and instauration of replicative senescence.
    Marino Gammazza A; Campanella C; Barone R; Caruso Bavisotto C; Gorska M; Wozniak M; Carini F; Cappello F; D'Anneo A; Lauricella M; Zummo G; Conway de Macario E; Macario AJ; Di Felice V
    Cancer Lett; 2017 Jan; 385():75-86. PubMed ID: 27836734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FBW7 increases chemosensitivity in hepatocellular carcinoma cells through suppression of epithelial-mesenchymal transition.
    Yu J; Zhang W; Gao F; Liu YX; Chen ZY; Cheng LY; Xie SF; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2014 Apr; 13(2):184-91. PubMed ID: 24686546
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition enhancer of zeste homologue 2 promotes senescence and apoptosis induced by doxorubicin in p53 mutant gastric cancer cells.
    Bai J; Ma M; Cai M; Xu F; Chen J; Wang G; Shuai X; Tao K
    Cell Prolif; 2014 Jun; 47(3):211-8. PubMed ID: 24738879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. p53-dependent induction of prostate cancer cell senescence by the PIM1 protein kinase.
    Zemskova M; Lilly MB; Lin YW; Song JH; Kraft AS
    Mol Cancer Res; 2010 Aug; 8(8):1126-41. PubMed ID: 20647331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PMA induces androgen receptor downregulation and cellular apoptosis in prostate cancer cells.
    Itsumi M; Shiota M; Yokomizo A; Takeuchi A; Kashiwagi E; Dejima T; Inokuchi J; Tatsugami K; Uchiumi T; Naito S
    J Mol Endocrinol; 2014 Aug; 53(1):31-41. PubMed ID: 24780839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.